ACAD
32.04
-0.55
-1.69%
AEMD
0.237
+0.01
+4.405%
APRI
1.83
-0.04
-2.14%
ARNA
4.31
-0.06
-1.37%
ATEC
1.42
-0.03
-2.07%
CNAT
6.81
-0.31
-4.35%
CRXM
0.194
-0.001
-0.3079%
CYTX
1.17
-0.01
-0.85%
DXCM
61.49
-0.85
-1.36%
GNMK
12.27
-0.71
-5.47%
HALO
14.67
+0.39
+2.73%
ILMN
182.21
-3.43
-1.85%
INNV
0.142
+0.002
+1.0714%
INO
8.47
+0.31
+3.80%
ISCO
0.054
-0.004
-6.574%
ISIS
63.18
-0.49
-0.77%
LGND
77.45
+0.34
+0.44%
LPTN
2.34
-0.13
-5.26%
MBVX
1.91
+0.04
+2.1444%
MEIP
1.79
0.00
0.00%
MNOV
3.55
+0.05
+1.43%
MRTX
29.11
-0.21
-0.72%
MSTX
0.461
-0.025
-5.0515%
NBIX
39.9
+0.19
+0.48%
NUVA
45.6
-0.39
-0.85%
ONCS
0.326
-0.01
-2.8358%
ONVO
3.59
+0.05
+1.41%
OREX
7.68
-0.15
-1.92%
OTIC
34.6
-0.76
-2.15%
QDEL
26.15
-0.83
-3.08%
RCPT
173.44
+8.55
+5.19%
RGLS
17.45
+0.51
+3.01%
RMD
71.39
-0.39
-0.54%
SCIE
0.03
0.00
0.00%
SPHS
0.59
+0.01
+1.92%
SRNE
11.39
-0.17
-1.47%
TROV
6.75
-0.06
-0.88%
VICL
0.94
0.00
-0.52%
VOLC
17.99
0.00
0.00%
ZGNX
1.44
+0.07
+5.11%
ACAD
32.04
-0.55
-1.69%
AEMD
0.237
+0.01
+4.405%
APRI
1.83
-0.04
-2.14%
ARNA
4.31
-0.06
-1.37%
ATEC
1.42
-0.03
-2.07%
CNAT
6.81
-0.31
-4.35%
CRXM
0.194
-0.001
-0.3079%
CYTX
1.17
-0.01
-0.85%
DXCM
61.49
-0.85
-1.36%
GNMK
12.27
-0.71
-5.47%
HALO
14.67
+0.39
+2.73%
ILMN
182.21
-3.43
-1.85%
INNV
0.142
+0.002
+1.0714%
INO
8.47
+0.31
+3.80%
ISCO
0.054
-0.004
-6.574%
ISIS
63.18
-0.49
-0.77%
LGND
77.45
+0.34
+0.44%
LPTN
2.34
-0.13
-5.26%
MBVX
1.91
+0.04
+2.1444%
MEIP
1.79
0.00
0.00%
MNOV
3.55
+0.05
+1.43%
MRTX
29.11
-0.21
-0.72%
MSTX
0.461
-0.025
-5.0515%
NBIX
39.9
+0.19
+0.48%
NUVA
45.6
-0.39
-0.85%
ONCS
0.326
-0.01
-2.8358%
ONVO
3.59
+0.05
+1.41%
OREX
7.68
-0.15
-1.92%
OTIC
34.6
-0.76
-2.15%
QDEL
26.15
-0.83
-3.08%
RCPT
173.44
+8.55
+5.19%
RGLS
17.45
+0.51
+3.01%
RMD
71.39
-0.39
-0.54%
SCIE
0.03
0.00
0.00%
SPHS
0.59
+0.01
+1.92%
SRNE
11.39
-0.17
-1.47%
TROV
6.75
-0.06
-0.88%
VICL
0.94
0.00
-0.52%
VOLC
17.99
0.00
0.00%
ZGNX
1.44
+0.07
+5.11%

Headline »

March 2, 2015 – 7:18 pm

In 2011 the San Diego Biotechnology Network (SDBN) hosted an event on “virtual” drug discovery, the then burgeoning idea that successful therapies could result from very small companies that rely on the internet-driven infrastructure to …

Read the full story »

Breaking San Diego Biotech News

NuVasive CEO resigns over expense violations

April 1, 2015 – 12:34 pm

Founder Alex Lukianov built NuVasive into a formidable spinal surgery specialist.

NuVasive CEO Resigns After Probe of Personnel and Policy Violations

April 1, 2015 – 11:50 am

San Diego-based NuVasive (NASDAQ: NUVA), which makes specialized surgical products for use in spinal surgery, said today that chairman and CEO Alex Lukianov has resigned over violations of the…

[[Click headline to continue reading.]]

San Diego biotech raises $76M

April 1, 2015 – 10:25 am

San Diego’s aTyr Pharma testing drug for severe genetic muscle disease.

Equity Crowdfunding Backers Clash Over Fundraising Limits in States

April 1, 2015 – 8:29 am

After five years of bootstrapping his startup, Instancy, Harvey Singh’s company has a finished education software product, revenue, and a growing roster of employees. As Singh looks overseas to…

[[Click headline to continue reading.]]


See All News>>

Newest San Diego Biotech Jobs

Scientific Program Manager – Salk Institute for Biological Studies – E627

Position Description:
Incumbent will serve as project manager for preclinical and clinical research efforts including guidance, strategy and execution. Duties include but are not limited to: leadership of project team, supervision of technicians, managing pre-clinical strategies …

**Research Associate/Synthetic Chemist**

Top Three Skills: small molecule synthesis, NMR, LCMS, MS
Job Description: The successful candidate will be an accomplished synthetic/process chemist with state of the art knowledge of synthetic organic chemistry and high-throughput parallel synthes […

Process Development Associate wanted for Biotech company (Sorrento Valley)

Our large Biotech Company is in need of a Process Development Associate!
We are seeking recent grads wanting lab experience
M-F, 8:00am-5:00pm
Long term temp position
$15/hr.
Please submit word formatted resume + professional references for imme […

Chemist – Production Chemist (Carlsbad, CA)

SynergEyes? is the only high-performance, advanced technology and OD-led contact lens company focused exclusively on leading independent eye care professionals. SynergEyes prides itself in providing over 10,000 eye care professionals products that de […


See All Jobs>>

San Diego Biotech Blog Feed

Trilink: Liquid Biopsies Are Viewed as “Liquid Gold” for Diagnostics

Invasive Needles and Scalpels Seen as Passé Noninvasive Sampling Advocates Focusing on Circulating Tumor Cells (CTCs)  New Companies are Pursuing the Liquid Biopsy “Gold Rush” Biopsy Basics As defined in Wikipedia, a biopsy is ‘a medical test commonly performed by … Continue reading →... More...

Membrane Penetration: The Super Fins!

Hello! I am going to be writing some articles for a cool new aquatic news website called The Super Fins. Check out my first piece!  Meet the Notothenioid Fish: Antarctic Icefish Uses Antifreeze in Blood to Survive... More...

Ryon Graf: STEAM day at Muirlands Middle School

29 March 2015 About a week ago I had the honor and privilege to attend Muirlands Middle School’s STEAM career day as an invited speaker. The last time I set foot on the Muirlands campus I was a student. As I walked by the front gate I had the distinct recollection of the sound of... More...

Su Lab: What the heck is NGLY1 and why is Mark2Cure targeting it in the next campaign?

NGLY1 is the gene encoding for Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) AKA N-glycanase 1. A deficiency in this enzyme can disrupt protein quality control mechanisms in the cell, which as we’ve seen in the BioGPS Gene-of-the-week on BAG6 is very important. Learn... More...